Acute Myeloid Leukemia
mTOR regulates cell survival after etoposide treatment in primary AML cells
Published in Cancer Weekly, February 21st, 2006
According to a study from the United States, "Acute myeloid leukemia cells have constitutive activation of phosphatidylinositol 3(PI3) kinase and require PI3 kinase activation for survival; however, the function of the PI3 kinase pathway in the survival of leukemic cells is poorly defined."
"We have studied the role of one PI3 kinase substrate, mTOR (mammalian target of rapamycin), in primary leukemic cells. In initial experiments, we have defined a novel growth medium that improves survival of acute myeloid leukemia (AML) blasts in long-term suspension...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-02-21)
More Articles from Cancer Weekly
- Brain Cancer
TWIST is expressed in human gliomas and promotes invasion - Cancer Drugs
Doxorubicin-induced cardiotoxicity could be prevented by melatonin - Colorectal Metastases
Recent chemotherapy reduced sensitivity of FDG-PET in detecting colorectal metastases - Lung Cancer
JNK activation required for gemcitabine's cytotoxic effect in lung cancer - Pituitary Tumors
Mimecan gene expression used as a marker for diagnosing pituitary tumors - Acute Myeloid Leukemia
Modified conventional protocol for childhood AML well tolerated - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
